Pharma Industry

coronavirus antidote: Why the race to find an antidote against this wily virus goes beyond labs, research, and trials



While Russia claims to have found the first Covid-19 vaccine, the world has to deal with many contentious issues such as access, pricing, and commercial viability in its fight against the contagion.

Russia on Saturday said it has produced the first batch of its coronavirus vaccine. While it was the first country to register a Covid-19 vaccine, President Vladimir Putin’s announcement was met with caution from scientists and the World Health Organization. Anthony Fauci, the top United States infectious diseases expert, said he has serious doubts about Russia’s announcement. We at ET Prime have been tracking this very important topic very

  • SAVE

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise


Source link